11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation. - Wikidata - awgldk - TriplyDB

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.

http://www.wikidata.org/entity/Q36477149

about

Targeted Radionuclide Therapy: Practical Applications and Future Prospects Current Status of Hybrid PET/MRI in Oncologic Imaging Update on positron emission tomography for imaging of prostate cancer Metabolic Imaging in Prostate Cancer: Where We Are Metabolic pathways promoting cancer cell survival and growth Molecular Imaging of Prostate Cancer Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.Positron emission tomography (PET) in primary prostate cancer staging and risk assessment Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer.A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis The metabolic fate of acetate in cancer.Functional imaging for prostate cancer: therapeutic implications.Promise and pitfalls of quantitative imaging in oncology clinical trials.Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake Molecular imaging of urogenital diseases.Lipids and prostate cancer.Challenges in accurate registration of 3-D medical imaging and histopathology in primary prostate cancer 18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Functional and molecular imaging of localized and recurrent prostate cancer.Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature.Potential applications of image-guided radiotherapy for radiation dose escalation in patients with early stage high-risk prostate cancer.New prospects for PET in prostate cancer imaging: a physicist's viewpoint.Prostate Cancer Imaging with Novel PET Tracers.Molecular imaging probes derived from natural peptides.Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial.PET Tracers Beyond FDG in Prostate Cancer.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer.Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer [Focus on molecular imaging in prostate cancer].3D prostate histology image reconstruction: Quantifying the impact of tissue deformation and histology section location Metabolic activity of brown, "beige," and white adipose tissues in response to chronic adrenergic stimulation in male mice.Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer.Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer.¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.(11)C-acetate as a new biomarker for PET/CT in patients with multiple myeloma: initial staging and postinduction response assessment.Real-time DNP NMR observations of acetic acid uptake, intracellular acidification, and of consequences for glycolysis and alcoholic fermentation in yeast.Molecular imaging and fusion targeted biopsy of the prostate.Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial).

P2860

Q26745926-BF4661B1-A89C-48CD-BE74-7706E9FF1611 Q26825265-3E296C6D-BDC3-430A-94FB-407E20979083 Q27026828-7D40548B-2CA9-4EC8-9B2B-3E0CB5260659 Q28074429-9FC21D9F-C2A7-4A8C-9815-E331A95541FA Q28086940-DF626759-E6F5-4876-9736-0A31A1A35B1D Q33620520-2A120972-AA44-43D2-B95D-3C5F23F67792 Q33625371-49F4434D-0E65-4642-92E0-6FB945DCAC78 Q33890153-D3C5F267-DC9D-4213-857D-E0F87CEF0AD9 Q34084254-D26037E5-DE1C-48CD-9274-80843E41001E Q34448206-CC772794-639F-4732-ACE7-7817FDA18A95 Q34681143-28DD2C44-238D-4978-BDAB-BA486EEDCC45 Q36113718-608B75B2-92C9-448D-AC01-D2DC74F798F4 Q36128629-00D0217B-AC00-45D7-86DA-991763342C39 Q36303765-66F00206-6580-47CF-99A1-4CD1B1BA723E Q36533826-F02E4143-1DB2-46AF-81F4-CFE977D93D4E Q37550399-FD16BE06-0CE2-4931-9C00-1265DC7E647F Q38002682-8E4F6885-ECC0-4366-AABE-69F0FB01D7FA Q38090465-1614FA97-2625-4A2D-8A7B-8C38F9C3B65D Q38098441-BD8D9988-F72F-43C0-AC5B-76ADBD44B5C3 Q38104639-4598BA33-701A-48F3-A6BB-282B8F49DB69 Q38128388-20250B6C-DB99-4317-9556-507A60D51CDE Q38362692-544A37B0-2FD6-4F5C-8C7A-797E605BBA53 Q38616392-6C0F4057-2555-4A17-ABF2-F592488C0A61 Q38732369-061D0760-CC5F-4C7C-9400-8C3BA0A24D2C Q38748846-7EB92BAF-9B66-41CA-9644-848A256AFA77 Q38924532-DB135E51-CEF7-4EC4-8D66-79BE6766CC06 Q39003086-679AA34D-A742-49D3-B195-2E5A61F73405 Q39307896-AA1E67E2-DB8B-45B1-802C-FA7FEBA5DCE6 Q39438297-89F7DBB9-49C3-493F-9D8D-E837C45A8F88 Q40487460-12581710-2581-4A04-B964-798FEAC45D81 Q41585395-2620EC64-FD51-4426-BD68-2A8E608F14C5 Q41868904-D87C6453-3B42-4642-9B3F-9B44DCB56F8B Q42053331-6EF517FB-4699-45E6-BBA7-94A62FC89C38 Q42060482-1586815F-8F67-4DFD-8DA6-4894DA65F6D1 Q42230054-D2A47097-667E-48C5-84D0-02A0E3D12A33 Q43156292-0EF78651-6B8F-4EBA-9ADD-446CCF724A61 Q43672014-A8016CD3-9B2A-4FFD-AFDE-09B870C36B24 Q45228057-9E811B6D-B6A3-469A-9680-FD6B0B6F09F2 Q47608215-C2F27914-53A5-4B6F-8F74-74CAAB5E7FC7 Q49939705-1785D7CF-9D95-4EEB-92A3-01E6BDE0D406

P2860

11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.

http://www.wikidata.org/entity/Q36477149

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@ast

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@en

type

label

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@ast

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@en

prefLabel

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@ast

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@en

P1433

Q36477149-BFCBC9B7-2FA2-4CFF-B3EE-19D957E53F4E

P1476

Q36477149-0413D4FF-E565-4C3C-97EA-49A81B58ABA8

P2093

Q36477149-1463C7C7-ADCC-474B-9140-EF0D4A69C624

Q36477149-246E3771-7A36-4C6E-B273-95F8D9766EE5

Q36477149-3D6525DE-B9F7-4717-A6C2-B0408C94AED4

Q36477149-5F1AA632-3A02-43A0-A2CA-00282925EC8F

Q36477149-66BB78C2-B9B5-4942-B7CD-930D6C995AD7

Q36477149-6A004258-799E-49CC-AE11-2BAE7F530D2A

Q36477149-8FE30A3A-951D-43A2-9149-11921987F071

Q36477149-A06272D9-51F7-4E91-AD4D-92CD19168586

Q36477149-A1FCD1F6-E173-44E0-85C6-4CA3F7D94871

Q36477149-A717E28D-923A-4CAC-9908-14556C2C6306

P2860

Q36477149-14E68776-DBBD-471B-8AA0-A8E6094A081A

Q36477149-2AA2029C-FD21-4B1A-B04B-D0FFC7DCF40D

Q36477149-32A43857-172D-409D-B627-8F51D55661AA

Q36477149-47A515C8-4D04-4D99-82CE-9CE521DACCB8

Q36477149-66AA36F4-432E-443D-AF7F-F89C1234F25F

Q36477149-73B77836-2D7B-40AE-906D-6A1457C473B7

Q36477149-83711BC3-90A8-4FA9-B4A3-C58D7F7FE382

Q36477149-981EEE32-8BDC-4B5A-B732-7CAF84B13258

Q36477149-9B449F4C-6624-44A2-AB95-D070EE43A76E

Q36477149-9E66D867-333F-47C7-8B33-1C5A19310DD5

P304

Q36477149-17AC1C15-1CC5-4AA8-80F5-9D33826A4AE1

P31

Q36477149-B5569854-A634-47C6-BF7A-3184308B03B6

P356

Q36477149-D277A759-9656-4FEC-AEE2-AA41F7771C21

P407

Q36477149-A5376E72-2214-47B6-925E-7F94898CCEFD

P433

Q36477149-D579A69B-57AA-4FA2-9216-3154D638F97E

P478

Q36477149-3365F034-0C6F-42C7-9F7C-287ECF28E89E

P577

Q36477149-6195C478-57B6-45AA-9D48-DE44C12CF598

P5875

Q36477149-8607437E-BE4E-4A0E-A674-BE6801F51460

P698

Q36477149-1EA19267-CCE4-4ED6-B2E0-6A83AD6F1604

P932

Q36477149-2C85A6C1-0A25-46BC-BE59-834E85C7475B

P356

JNUMED.111.096032

P1433

The Journal of Nuclear Medicine

P1476

11C-Acetate PET/CT in localize ...... d histopathologic correlation.

@en

P2093

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Dagane Daar

http://www.w3.org/2001/XMLSchema#string

Esther Mena

http://www.w3.org/2001/XMLSchema#string

Gideon Kwarteng

http://www.w3.org/2001/XMLSchema#string

Haresh Mani

http://www.w3.org/2001/XMLSchema#string

Karen A Kurdziel

http://www.w3.org/2001/XMLSchema#string

Marcelino Bernardo

http://www.w3.org/2001/XMLSchema#string

Maria J Merino

http://www.w3.org/2001/XMLSchema#string

Maria L Lindenberg

http://www.w3.org/2001/XMLSchema#string

Peter A Pinto

http://www.w3.org/2001/XMLSchema#string

P2860

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer.

Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation

Positron emission tomography for prostate, bladder, and renal cancer.

Imaging localized prostate cancer: current approaches and new developments.

Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.

Distribution volume ratios without blood sampling from graphical analysis of PET data.

The roles of PET and PET/CT in the diagnosis and management of prostate cancer.

A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds

Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells.

P304

538-545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2967/JNUMED.111.096032

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221841054

http://www.w3.org/2001/XMLSchema#string

P698

22343504

http://www.w3.org/2001/XMLSchema#string

P932

3526004

http://www.w3.org/2001/XMLSchema#string